Approximately 70 million surgical and procedure-based wounds are created each year in surgeries worldwide that offer potential for adjunctive products for surgical closure and securement. Some 23 million of these wounds are created during surgical procedures in the United States. Although it is possible that healing of all these wounds would be improved through use [...]
The market for "surgical securement" products is subdivided into the following product categories: sutures, staples and other mechanical closure devices tapes hemostats fibrin and other sealants high-strength medical adhesives post-surgical adhesion prevention. The total securement market is forecast over the next four years at a compound annual growth rate of 8.4%. Definition of Surgical Closure and [...]
The worldwide market for products used in securement (sutures, staple, hemostasis, tapes, surgical sealants, high-strength glues) is characterized by both well established markets (sutures, staples and tapes) and novel products (surgical sealants, hemostasis and high-strength glues). The attractiveness of the surgical securement market is that there are some sizable segments that continue to demonstrate high [...]
A useful starting point for determining which adjunctive surgical closure and securement products are appropriate for different wound healing treatments is to recognize the major distinction between different wound types. Surgical wounds are usually appropriate for treatment with adjunctive surgical closure and securement products because they are created under clean conditions, the usual acute healing [...]
The tissue closure and securement market can be regarded as a benchmark indicator for overall expansion of medical device usage. This is because surgical closure and securement products are growing to be components of all surgical procedures. These products are used for rapid and efficient closure of surgical wounds, and internal securement of tissues to [...]
During the 19th century, surgeons began to experiment with materials designed to achieve hemostasis: gelatin, collagen, natural fabrics, and thrombin and fibrin materials. In the early 1980s today’s commercial products began to appear. They were rapidly adopted in Japan where bleeding is an extremely emotive issue, and also in Europe where local regulatory requirements allowed [...]
Hemostatic agents have been used for over a hundred years to prevent bleeding in the surgical situation. Primarily these products were first introduced to prevent hematomas during surgery with the aim of preventing resultant infections. During the 1980s and 1990s, the popularity of hemostats increased rapidly as surgeons tried to avoid excessive use of blood transfusions [...]
Contact:
